sources/source-baumol-cost-disease-digest.md

Provenance: collaborative. How Civic Blueprint labels human and AI collaboration.

Source Digest — Baumol, Cost Disease

Status (April 2026): Complete standard digest. Two thematic clusters: (1) the mechanism — why labor-intensive services get systematically more expensive; (2) the policy implication — cost disease is not a failure, it is a success. This is the single most important source for correctly interpreting the Perry "Chart of the Century."


Source identification

Author
Value
William J. Baumol (1922–2017; Princeton and NYU)
Canonical paper
Value
"Macroeconomics of Unbalanced Growth: The Anatomy of Urban Crisis," American Economic Review 57(3), 1967
Book
Value
The Cost Disease: Why Computers Get Cheaper and Health Care Doesn't, Yale UP, 2012

Thematic cluster 1: the mechanism

Core claims

  • Economies have two sectors in Baumol's framework:
    • Progressive sector — characterized by rapid productivity growth (manufacturing, computing, much of tradable goods). Output per worker rises quickly; unit costs fall.
    • Stagnant sector — characterized by slow productivity growth (live services: healthcare, education, performing arts, childcare, personal services). Output per worker rises slowly; each unit still requires roughly the same labor input over time.
  • In a competitive labor market, wages across both sectors must rise at roughly similar rates because workers can move between sectors.
  • The consequence: stagnant-sector wages rise at the progressive-sector productivity rate, but stagnant-sector productivity does not. Stagnant-sector unit costs therefore rise at the difference between wage growth and productivity growth — i.e., roughly at the progressive-sector productivity growth rate.
  • Over decades, this creates massive relative-price shifts. If manufacturing productivity grows 3%/yr and healthcare productivity grows 0.5%/yr, relative healthcare prices rise 2.5%/yr compounding. Over 50 years, that's a 3.4x relative price increase — roughly matching the observed U.S. pattern for healthcare, education, and childcare.
  • This is not inefficiency. It is the price mechanism correctly signaling that labor-intensive services are becoming relatively more scarce as the rest of the economy gets more productive. Without cost disease, either workers would leave the stagnant sector entirely (if their wages failed to rise), or the services would stop being provided.

Thematic cluster 2: the policy implication

Core claims

  • Because cost disease is driven by relative productivity and not by institutional failure, it cannot be "solved" by market deregulation or government withdrawal. A purely market-based healthcare system is still subject to cost disease; so is a purely socialized system. The evidence: cost disease appears in all OECD healthcare systems regardless of their institutional structure.
  • However, cost disease is affordable in absolute terms because the progressive sector gets so much cheaper. As long as productivity growth in the progressive sector outpaces cost disease in the stagnant sector, the nation as a whole can afford more stagnant-sector services, not fewer. Baumol explicitly argues that fears about healthcare bankrupting society are misplaced: we are getting richer fast enough to afford more healthcare.
  • The policy question is therefore not "how do we stop cost disease?" but "how do we distribute the absolute gains?" The reason healthcare appears unaffordable to individuals is that the distribution of progressive-sector productivity gains has concentrated, leaving individuals without the income growth to match rising stagnant-sector prices. This is a distributional problem, not a productivity problem.
  • For the exchange, this means that the Perry chart is not primarily evidence about government failure in specific sectors. It is evidence about (i) the underlying structural shift in a maturing economy and (ii) the distributional failure to share progressive-sector gains broadly enough to keep stagnant-sector services affordable at the individual level.

Representative excerpt (from the 2012 book)

"The cost disease is a remarkable phenomenon. Paradoxically, the reason our health care, our education, and our symphonies are more expensive is that we are better off. They are expensive because our computers are cheap, because our manufacturing is productive, because our agricultural output has soared. The question is not how to cure the disease — there is no cure, because there is no disease — but how to distribute the cure's effects."

Research context

Mechanism is empirically robust
Evidence
Corroborated
Context
See Nordhaus (2008) for a review; reproduced across OECD data.
Cost disease appears across institutional types
Evidence
Corroborated
Context
OECD health-cost trajectories confirm this; cost disease occurs in both NHS-style and U.S.-style systems, though the U.S. level is higher due to additional institutional inefficiencies.
Cost disease is affordable in the aggregate
Evidence
Corroborated in principle, problematic in distribution
Context
Aggregate affordability is arithmetic; distributional affordability depends on whether productivity gains are broadly shared. See Piketty, Capital.
The "solution" is distributional, not deregulatory
Evidence
Debated
Context
Most economists accept the core analysis; the distributional remedies are politically contested.

Interpretive notes

  • Baumol's framework is the project's most important analytical tool for Sub-debate 6. Without it, the Perry chart reads as a damning indictment of government involvement. With it, the chart reads as a predictable consequence of the productivity-distribution divergence of the last half century, amplified in specific sectors by supply-side restrictions and rent-extraction structures.
  • The synthesis for the project is: cost disease accounts for roughly the overall trajectory (the fact that healthcare, education, and childcare get relatively more expensive over time); supply-side restrictions account for the additional U.S.-specific inflation (housing zoning, certificate-of-need, residency caps); rent extraction accounts for additional level differences (U.S. healthcare prices are higher than peer countries at the same quality); distribution failure accounts for why individuals experience it as a crisis (wages have not kept pace with progressive-sector productivity).
  • This decomposition is essential for the project's reform program. Each driver has a different remedy: cost disease requires distributional reform (broad income growth, public financing, universal risk-pooling); supply-side restrictions require deregulation (YIMBY, CON reform); rent extraction requires countervailing institutions (price negotiation, antitrust, transparency); distribution failure requires wage-and-wealth reform.
  • For the Ratchet Problem, cost disease creates a structural pressure on public budgets that is distinct from capture dynamics. Healthcare and education spending rise because the underlying prices rise. Interpreting this pressure as "ratchet" in the Higgs sense misreads its nature.

Project 2028 mapping


Cross-references

Relationship
Baumol is the single most important lens on Perry's data.
Relationship
Empirical decomposition of U.S. healthcare price divergence.
Relationship
The distributional side of the cost-disease story.
Relationship
Klein-Thompson's supply-side critique complements Baumol's distributional critique.